JP2014209134A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2014209134A5 JP2014209134A5 JP2014163615A JP2014163615A JP2014209134A5 JP 2014209134 A5 JP2014209134 A5 JP 2014209134A5 JP 2014163615 A JP2014163615 A JP 2014163615A JP 2014163615 A JP2014163615 A JP 2014163615A JP 2014209134 A5 JP2014209134 A5 JP 2014209134A5
- Authority
- JP
- Japan
- Prior art keywords
- lupus anticoagulant
- absence
- blood
- time
- determining
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2014163615A JP6025105B2 (ja) | 2011-06-17 | 2014-08-11 | ループスアンチコアグラント検出用血液凝固時間の測定方法 |
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2011135174 | 2011-06-17 | ||
| JP2011135174 | 2011-06-17 | ||
| JP2014163615A JP6025105B2 (ja) | 2011-06-17 | 2014-08-11 | ループスアンチコアグラント検出用血液凝固時間の測定方法 |
Related Parent Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2013520613A Division JP5640189B2 (ja) | 2011-06-17 | 2012-06-15 | ループスアンチコアグラント検出用血液凝固時間の測定方法 |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2014209134A JP2014209134A (ja) | 2014-11-06 |
| JP2014209134A5 true JP2014209134A5 (https=) | 2015-08-06 |
| JP6025105B2 JP6025105B2 (ja) | 2016-11-16 |
Family
ID=47357238
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2013520613A Active JP5640189B2 (ja) | 2011-06-17 | 2012-06-15 | ループスアンチコアグラント検出用血液凝固時間の測定方法 |
| JP2014163615A Active JP6025105B2 (ja) | 2011-06-17 | 2014-08-11 | ループスアンチコアグラント検出用血液凝固時間の測定方法 |
Family Applications Before (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2013520613A Active JP5640189B2 (ja) | 2011-06-17 | 2012-06-15 | ループスアンチコアグラント検出用血液凝固時間の測定方法 |
Country Status (8)
| Country | Link |
|---|---|
| US (1) | US9970046B2 (https=) |
| EP (1) | EP2722675B1 (https=) |
| JP (2) | JP5640189B2 (https=) |
| KR (1) | KR102001662B1 (https=) |
| CN (1) | CN103688177B (https=) |
| CA (1) | CA2839125C (https=) |
| ES (1) | ES2613723T3 (https=) |
| WO (1) | WO2012173260A1 (https=) |
Families Citing this family (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN115144601A (zh) * | 2015-03-20 | 2022-10-04 | 株式会社日立高新技术 | 自动分析装置以及自动分析方法 |
| JP6499488B2 (ja) * | 2015-03-31 | 2019-04-10 | 学校法人東日本学園 | 凝固時間の測定方法、ループスアンチコアグラントの存否の判定方法及びループスアンチコアグラント検出用試薬キット |
| JP6871673B2 (ja) * | 2015-03-31 | 2021-05-12 | 学校法人東日本学園 | 血液検体を判定するための方法、装置及びコンピュータプログラム、並びに血液検体分析装置 |
| WO2017189294A1 (en) | 2016-04-25 | 2017-11-02 | Instrumentation Laboratory Company | Method and kit for identifying lupus anticoagulant (la) associated with antiphospholipid syndrome |
| JP6837851B2 (ja) * | 2017-01-31 | 2021-03-03 | シスメックス株式会社 | 血液検体の判定方法、並びに血液検体の分析のための装置及びコンピュータプログラム |
| CN108761104A (zh) * | 2018-05-21 | 2018-11-06 | 深圳优迪生物技术有限公司 | 凝血激活剂及其应用 |
| CN109709344A (zh) * | 2018-12-29 | 2019-05-03 | 贵州金玖生物技术有限公司 | 一种活化凝血检测试剂、其制备方法及其应用 |
| EP3919913A4 (en) * | 2019-01-31 | 2022-11-09 | Sekisui Medical Co., Ltd. | METHOD OF ANALYSIS OF BLOOD COAGULATION CHARACTERISTICS OF A BLOOD SAMPLE |
| CN112557665B (zh) * | 2020-11-10 | 2023-06-09 | 北京美创新跃医疗器械有限公司 | 一种狼疮抗凝物的确认试剂及其制备方法 |
| CN114778858A (zh) * | 2022-06-23 | 2022-07-22 | 深圳市帝迈生物技术有限公司 | 一种狼疮抗凝物检测试剂盒 |
Family Cites Families (17)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE2461969A1 (de) | 1974-12-31 | 1976-07-08 | Behringwerke Ag | Stabiles blutplasma, verfahren zu dessen herstellung und seine verwendung als vergleichsplasma bei gerinnungs- untersuchungen |
| JPH0650999B2 (ja) | 1988-09-12 | 1994-07-06 | 日本商事株式会社 | 血液凝固因子安定化法 |
| US4877741A (en) * | 1988-10-24 | 1989-10-31 | The United States Of America As Represented By The Secretary Of The Air Force | Treatment of human plasma with brown recluse spider toxin to emulate a lupus anticoagulant |
| AU6067190A (en) | 1989-07-20 | 1991-02-22 | Analytical Control Systems, Inc. | Improved stable coagulation controls |
| JPH06324048A (ja) | 1993-05-15 | 1994-11-25 | Shimizu Seiyaku Kk | 血液凝固能検査用試薬及び血液凝固能の検査方法 |
| DE19749197A1 (de) * | 1997-11-07 | 1999-05-12 | Dade Behring Marburg Gmbh | Verfahren zur Bestimmung des antikoagulatorischen Potentials einer Probe |
| JP4370071B2 (ja) * | 1999-12-24 | 2009-11-25 | シスメックス株式会社 | 複合因子血液凝固能測定試薬 |
| CN1126758C (zh) | 2001-08-16 | 2003-11-05 | 四川高维系统工程技术有限公司 | 凝血因子ⅸ复合物的制备方法 |
| KR101006070B1 (ko) | 2001-12-21 | 2011-01-06 | 노보 노르디스크 헬스 케어 악티엔게젤샤프트 | 인자 ⅶ 폴리펩티드의 액체 조성물 |
| RU2364626C2 (ru) | 2003-03-18 | 2009-08-20 | Ново Нордиск Хелт Кэр Аг | Способ получения, способ очистки и способ стабилизации полипептидов фактора vii, ix и x |
| EP1707634A1 (en) | 2005-03-29 | 2006-10-04 | Octapharma AG | Method for isolation of recombinantly produced proteins |
| WO2007018511A1 (en) | 2005-07-28 | 2007-02-15 | American Diagnostica Inc. | Lupus anticoagulant testing |
| CN101221189B (zh) | 2007-01-12 | 2012-08-15 | 上海太阳生物技术有限公司 | 一种用于测定活化部分凝血活酶时间aptt的体外诊断试剂盒 |
| WO2009065918A1 (en) | 2007-11-22 | 2009-05-28 | Novo Nordisk Health Care Ag | Stabilisation of liquid-formulated factor vii(a) polypeptides by aldehyde-containing compounds |
| AU2008340304B2 (en) | 2007-12-21 | 2016-03-03 | Aptevo Biotherapeutics Llc | Stabilized factor IX formulations containing trehalose |
| CN102066947B (zh) * | 2008-06-18 | 2015-10-14 | 积水医疗株式会社 | 凝血时间延长原因的判定方法 |
| KR20160104740A (ko) | 2008-06-24 | 2016-09-05 | 옥타파마 아게 | 응고 인자 ｖｉｉｉ을 정제하는 방법 |
-
2012
- 2012-06-15 JP JP2013520613A patent/JP5640189B2/ja active Active
- 2012-06-15 WO PCT/JP2012/065434 patent/WO2012173260A1/ja not_active Ceased
- 2012-06-15 KR KR1020137033385A patent/KR102001662B1/ko active Active
- 2012-06-15 EP EP12801236.6A patent/EP2722675B1/en active Active
- 2012-06-15 ES ES12801236.6T patent/ES2613723T3/es active Active
- 2012-06-15 CN CN201280029832.5A patent/CN103688177B/zh active Active
- 2012-06-15 CA CA2839125A patent/CA2839125C/en active Active
- 2012-06-15 US US14/127,041 patent/US9970046B2/en active Active
-
2014
- 2014-08-11 JP JP2014163615A patent/JP6025105B2/ja active Active
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2014209134A5 (https=) | ||
| Gosselin et al. | The laboratory's 2015 perspective on direct oral anticoagulant testing | |
| Yuan et al. | Comparing the prothrombin time INR versus the APTT to evaluate the coagulopathy of acute trauma | |
| Bonar et al. | Overview of hemostasis and thrombosis and contribution of laboratory testing to diagnosis and management of hemostasis and thrombosis disorders | |
| Fontana et al. | Impact of rivaroxaban on point-of-care assays | |
| Mani et al. | Point-of-care coagulation testing for assessment of the pharmacodynamic anticoagulant effect of direct oral anticoagulant | |
| Hugenholtz et al. | The platelet and platelet function testing in liver disease | |
| JP6025105B2 (ja) | ループスアンチコアグラント検出用血液凝固時間の測定方法 | |
| Jeong et al. | Quantification of both platelet count and fibrinogen concentration using maximal clot firmness of thromboelastometry during liver transplantation | |
| Hayward et al. | Laboratory investigations for bleeding disorders | |
| Glas et al. | Sample transport by pneumatic tube system alters results of multiple electrode aggregometry but not rotational thromboelastometry | |
| Gudmundsdottir et al. | Critical role of factors II and X during coumarin anticoagulation and their combined measurement with a new Fiix-prothrombin time | |
| Gosselin et al. | Evaluating the use of commercial drug-specific calibrators for determining PT and APTT reagent sensitivity to dabigatran and rivaroxaban | |
| BR112015009932A8 (pt) | métodos | |
| IN2013MN01890A (https=) | ||
| Efthymiou et al. | Thrombin generation and factor X assays for the assessment of warfarin anticoagulation in thrombotic antiphospholipid syndrome | |
| CN102066947A (zh) | 凝血时间延长原因的判定方法 | |
| Dempfle et al. | Point of care coagulation tests in critically ill patients | |
| BR112014006741A2 (pt) | método para monitorização, diagnóstico e/ou prognóstico de lesão renal aguda no estágio inicial | |
| Tanaka et al. | Diagnosis of perioperative coagulopathy—plasma versus whole blood testing | |
| Douxfils et al. | Does the Russell viper venom time test provide a rapid estimation of the intensity of oral anticoagulation? A cohort study | |
| Görlinger et al. | Whole blood assay: thromboelastometry | |
| Blasi et al. | Reliability of thromboelastometry for detecting the safe coagulation threshold in patients taking acenocoumarol after elective heart valve replacement | |
| Faraoni et al. | Goal-directed coagulation management in the perioperative period of cardiac surgery | |
| BR112017014097A2 (pt) | tira de teste e sistema e método para medir a concentração de glicose em amostra de sangue |